3 studies found for: "hereditary leiomyomatosis and renal cell cancer"
|1||Active, not recruiting||
A Phase II Study of Bevacizumab and Erlotinib in Subjects With Advanced Hereditary Leiomyomatosis and Renal Cell Cancer (HLRCC) or Sporadic Papillary Renal Cell Cancer
|2||Active, not recruiting||
Randomized Pilot Study for the Treatment of Cutaneous Leiomyomas With Botulinum Toxin
Hereditary Leiomyomatosis Renal Cell Cancer - Study of the Genetic Cause and the Predisposition to Renal Cancer
† Indicates status has not been verified in more than two years